Philip R. Hagerman is Director & 10% Owner at Diplomat Pharmacy, Inc. (DPLO). They have made 6 open-market trades across 1 company since 2015, most recently 2020-02-10.
CIK 0001618897
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DPLO | 33,259 | $133K |
Shares reported on the most recent Form 4, priced at the 2020-02-10 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 33% | 67% |
| Avg Move | -3.7% | +2.5% | -11.6% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DPLO | SELL | 2019-10-02 | 2019-10-04 | $4.80 | $13K | -0.2% | +19.9% | -17.0% |
| DPLO | SELL | 2018-09-14 | 2018-09-17 | $18.58 | $3.4M | +1.6% | +5.3% | -29.2% |
| DPLO | SELL | 2018-09-11 | 2018-09-13 | $19.05 | $6.9M | +4.2% | +0.8% | -20.1% |
| DPLO | SELL | 2018-03-09 | 2018-03-12 | $20.65 | $58.3M | -6.1% | -12.5% | +13.0% |
| DPLO | SELL | 2015-12-07 | 2015-12-08 | $33.60 | $38.2M | -10.9% | -0.8% | -18.6% |
| DPLO | SELL | 2015-03-25 | 2015-03-27 | $29.00 | $38.5M | -10.9% | +2.2% | +2.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.